Otitis media among high-risk populations: Can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 9, 2013, Pages 1101-1110

  John, M ^a   Dunne, E M ^b   Licciardi, P V ^b   Satzke, C ^a,b   Wijburg, O ^a   Robins Browne, R M ^a,b   O'Leary, S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN A; PLACEBO; PNEUMOCOCCUS VACCINE; PROBIOTIC AGENT;

ABORIGINE; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; AUSTRALIA; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; BIFIDOBACTERIUM; CHILD NUTRITION; CONTROLLED CLINICAL TRIAL (TOPIC); CROWDING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL SANITATION; HAEMOPHILUS INFLUENZAE; HEALTH CARE ACCESS; HIGH RISK PATIENT; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INDIGENOUS PEOPLE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MICROBIAL COMMUNITY; MORAXELLA CATARRHALIS; NASOPHARYNX; NONHUMAN; OTITIS MEDIA; PARENTAL SMOKING; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; RISK REDUCTION; SMOKE; SOCIAL STATUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS THERMOPHILUS;

CHILD, PRESCHOOL; HUMANS; INFANT; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; POPULATION GROUPS; PROBIOTICS; RISK; STREPTOCOCCUS PNEUMONIAE;

EID: 84882696686     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1858-0     Document Type: Review

References (112)

1. Granström G (2009) Middle ear infections. Periodontol 2000 49:179-193
2. Lee HY, Andalibi A, Webster P, Moon SK, Teufert K, Kang SH, Li JD, Nagura M, Ganz T, Lim DJ (2004) Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis 4:12 (Pubitemid 39637313)
3. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM (2004) Otitis media. Lancet 363(9407):465-473 (Pubitemid 38210066)
4. Bluestone CD (2004) Studies in otitis media: Children's Hospital of Pittsburgh-University of Pittsburgh progress report - 2004. Laryngoscope 114(11 Pt 3 Suppl 105):1-26 (Pubitemid 39535732)
5. Bardach A, Ciapponi A, Garcia-Marti S, Glujovsky D, Mazzoni A, Fayad A, Colindres RE, Gentile A (2011) Epidemiology of acute otitis media in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol 75(9):1062-1070
6. Paradise JL, Rockette HE, Colborn DK, Bernard BS, Smith CG, Kurs-Lasky M, Janosky JE (1997) Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 99(3):318-333 (Pubitemid 27175999)
7. Hudson HM, Rockett IRH (1984) An environmental and demographic analysis of otitis media in rural Australian Aborigines. Int J Epidemiol 13(1):73-82 (Pubitemid 14162848)
8. Daly KA, Hoffman HJ, Kvaerner KJ, Kvestad E, Casselbrant ML, Homoe P, Rovers MM (2010) Epidemiology, natural history, and risk factors: panel report from the Ninth International Research Conference on Otitis Media. Int J Pediatr Otorhinolaryngol 74(3):231-240
9. Gunasekera H, Haysom L, Morris P, Craig J (2008) The global burden of childhood otitis media and hearing impairment: a systematic review. Pediatrics 121:S107
10. Dallaire F, Dewailly E, Vézina C, Bruneau S, Ayotte P (2006) Portrait of outpatient visits and hospitalizations for acute infections in Nunavik preschool children. Can J Public Health 97(5):362-368 (Pubitemid 44614008)
11. Morris PS, Leach AJ, Silberberg P, Mellon G, Wilson C, Hamilton E, Beissbarth J (2005) Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey. BMC Pediatr 5:27 (Pubitemid 41418280)
12. Coates HL, Morris PS, Leach AJ, Couzos S (2002) Otitis media in Aboriginal children: tackling a major health problem. Med J Aust 177(4):177-178 (Pubitemid 35021426)
13. Pettigrew MM, Gent JF, Pyles RB, Miller AL, Nokso-Koivisto J, Chonmaitree T (2011) Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol 49(11):3750-3755
14. Marom T, Nokso-Koivisto J, Chonmaitree T (2012) Viral-bacterial interactions in acute otitis media. Curr Allergy Asthma Rep 12(6):551-558
15. Smith-Vaughan H, Byun R, Nadkarni M, Jacques NA, Hunter N, Halpin S, Morris PS, Leach AJ (2006) Measuring nasal bacterial load and its association with otitis media. BMC Ear Nose Throat Disord 6:10 (Pubitemid 43894409)
16. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, Tung Y (1997) Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis 175(6):1440-1445 (Pubitemid 27225048)
17. Kilpi T, Herva E, Kaijalainen T, Syrjänen R, Takala AK (2001) Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 20(7):654-662 (Pubitemid 32652315)
18. Hoa M, Syamal M, Schaeffer MA, Sachdeva L, Berk R, Coticchia J (2010) Biofilms and chronic otitis media: an initial exploration into the role of biofilms in the pathogenesis of chronic otitis media. Am J Otolaryngol 31(4):241-245
19. Diavatopoulos DA, Short KR, Price JT, Wilksch JJ, Brown LE, Briles DE, Strugnell RA, Wijburg OL (2010) Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J 24(6):1789-1798
20. Hall-Stoodley L, Nistico L, Sambanthamoorthy K, Dice B, Nguyen D, Mershon WJ, Johnson C, Hu FZ, Stoodley P, Ehrlich GD, Post JC (2008) Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol 8:173
21. Wiertsema SP, Leach AJ (2009) Theories of otitis media pathogenesis, with a focus on Indigenous children. Med J Aust 191(9 Suppl):S50-S54
22. Bogaert D, de Groot R, Hermans PWM (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4(3):144-154 (Pubitemid 38293138)
23. Kadioglu A, Weiser JN, Paton JC, Andrew PW (2008) The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6(4):288-301 (Pubitemid 351404773)
24. Cole PJ (1986) Inflammation: a two-edged sword - the model of bronchiectasis. Eur J Respir Dis Suppl 147:6-15 (Pubitemid 16017382)
25. Smith-Vaughan H, Byun R, Halpin S, Nadkarni MA, Jacques NA, Hunter N, Morris PS, Leach AJ (2008) Interventions for prevention of otitis media may be most effective if implemented in the first weeks of life. Int J Pediatr Otorhinolaryngol 72(1):57-61 (Pubitemid 350198653)
26. Könönen E (2005) Anaerobes in the upper respiratory tract in infancy. Anaerobe 11(3):131-136 (Pubitemid 40410636)
27. Pelton SI (2012) Regulation of bacterial trafficking in the nasopharynx. Paediatr Respir Rev 13(3):150-153
28. Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, van Gils E, Bruin J, Montijn R, Bonten M, Sanders E (2011) Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One 6(2):e17035
29. Hilty M, Qi W, Brugger SD, Frei L, Agyeman P, Frey PM, Aebi S, Mühlemann K (2012) Nasopharyngeal microbiota in infants with acute otitis media. J Infect Dis 205(7):1048-1055
30. Liu CM, Cosetti MK, Aziz M, Buchhagen JL, Contente-Cuomo TL, Price LB, Keim PS, Lalwani AK (2011) The otologic microbiome: a study of the bacterial microbiota in a pediatric patient with chronic serous otitis media using 16SrRNA gene-based pyrosequencing. Arch Otolaryngol Head Neck Surg 137(7):664-668
31. Kong K, Coates HLC (2009) Natural history, definitions, risk factors and burden of otitis media. Med J Aust 191(9 Suppl):S39-S43
32. Coates HL (2009) Current management of otitis media in Australia - foreword. Med J Aust 191(9 Suppl):S37
33. Williams CJ, Jacobs AM (2009) The impact of otitis media on cognitive and educational outcomes. Med J Aust 191(9 Suppl):S69-S72
34. Wiertsema SP, Chidlow GR, Kirkham LA, Corscadden KJ, Mowe EN, Vijayasekaran S, Coates HL, Harnett GB, Richmond PC (2011) High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media. J Med Virol 83(11):2008-2017
35. Binks MJ, Cheng AC, Smith-Vaughan H, Sloots T, Nissen M, Whiley D, McDonnell J, Leach AJ (2011) Viral-bacterial co-infection in Australian Indigenous children with acute otitis media. BMC Infect Dis 11:161
36. Yagupsky P, Porat N, Fraser D, Prajgrod F, Merires M, McGee L, Klugman KP, Dagan R (1998) Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis 177(4):1003-1012 (Pubitemid 28155155)
37. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, Dowell SF (2000) Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30(5):784-789
38. Brundage JF (2006) Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 6(5):303-312
39. Sá-Leão R, Nunes S, Brito-Avô A, Alves CR, Carriço JA, Saldanha J, Almeida JS, Santos-Sanches I, de Lencastre H (2008) High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study. J Clin Microbiol 46(1):225-234
40. Gwaltney JM Jr, Sande MA, Austrian R, Hendley JO (1975) Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis 132(1):62-68
41. Wadowsky RM, Mietzner SM, Skoner DP, Doyle WJ, Fireman P (1995) Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun 63(4):1153-1157
42. Speshock JL, Doyon-Reale N, Rabah R, Neely MN, Roberts PC (2007) Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun 75(6):3102-3111 (Pubitemid 46870196)
43. Short KR, Diavatopoulos DA, Thornton R, Pedersen J, Strugnell RA, Wise AK, Reading PC, Wijburg OL (2011) Influenza virus induces bacterial and nonbacterial otitis media. J Infect Dis 204(12):1857-1865
44. Short KR, Reading PC, Wang N, Diavatopoulos DA, Wijburg OL (2012) Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. MBio 3(5). pii: e00255-12
45. Park K, Lim DJ (1993) Development of secretory elements in murine tubotympanum: lysozyme and lactoferrin immunohistochemistry. Ann Otol Rhinol Laryngol 102(5):385-395 (Pubitemid 23143078)
46. Lim DJ, Chun YM, Lee HY, Moon SK, Chang KH, Li JD, Andalibi A (2000) Cell biology of tubotympanum in relation to pathogenesis of otitis media - a review. Vaccine 19(Suppl 1):S17-S25 (Pubitemid 32121715)
47. Nonomura N, Giebink GS, Zelterman D, Harada T, Juhn SK (1991) Middle ear fluid lysozyme source in experimental pneumococcal otitis media. Ann Otol Rhinol Laryngol 100(7):593-596
48. Veenhoven R, Bogaert D, Uiterwaal C, Brouwer C, Kiezebrink H, Bruin J, IJzerman E, Hermans P, de Groot R, Zegers B, Kuis W, Rijkers G, Schilder A, Sanders E (2003) Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361(9376):2189-2195 (Pubitemid 36782552)
49. Prellner K, Kalm O, Pedersen FK (1984) Pneumococcal antibodies and complement during and after periods of recurrent otitis. Int J Pediatr Otorhinolaryngol 7(1):39-49 (Pubitemid 14146026)
50. Koch A, Mølbak K, Homøe P, Sørensen P, Hjuler T, Olesen ME, Pejl J, Pedersen FK, Olsen OR, Melbye M (2003) Risk factors for acute respiratory tract infections in young Greenlandic children. Am J Epidemiol 158(4):374-384 (Pubitemid 41288805)
51. da Costa JL, Navarro A, Neves JB, Martin M (2004) Household wood and charcoal smoke increases risk of otitis media in childhood in Maputo. Int J Epidemiol 33(3):573-578 (Pubitemid 38997233)
52. Williams CJ, Coates HL, Pascoe EM, Axford Y, Nannup I (2009) Middle ear disease in Aboriginal children in Perth: analysis of hearing screening data, 1998-2004. Med J Aust 190(10):598-600
53. Moran DJ, Waterford JE, Hollows F, Jones DL (1979) Ear disease in rural Australia. Med J Aust 2(4):210-212 (Pubitemid 10166094)
54. Laufer AS, Metlay JP, Gent JF, Fennie KP, Kong Y, Pettigrew MM (2011) Microbial communities of the upper respiratory tract and otitis media in children. MBio 2(1):e00245-10
55. Gunasekera H, Knox S, Morris P, Britt H, McIntyre P, Craig JC (2007) The spectrum and management of otitis media in Australian indigenous and nonindigenous children: a national study. Pediatr Infect Dis J 26(8):689-692 (Pubitemid 47424637)
56. Bluestone CD (1998) Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment. Int J Pediatr Otorhinolaryngol 42(3):207-223 (Pubitemid 28044785)
57. O'Leary SJ, Triolo RD (2009) Surgery for otitis media among Indigenous Australians. Med J Aust 191(9 Suppl):S65-S68
58. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL (2010) Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the Pneumococcal Global Serotype Project. PLos Med 7(10). pii: e1000348
59. Prymula R, Kriz P, Kaliskova E, Pascal T, Poolman J, Schuerman L (2009) Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine 28(1):71-78
60. Massa HM, Cripps AW, Lehmann D (2009) Otitis media: viruses, bacteria, biofilms and vaccines. Med J Aust 191(9 Suppl):S44-S49
61. Prymula R, Hanovcova I, Splino M, Kriz P, Motlova J, Lebedova V, Lommel P, Kaliskova E, Pascal T, Borys D, Schuerman L (2011) Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine 29(10):1959-1967
62. Coker TR, Chan LS, Newberry SJ, Limbos MA, Suttorp MJ, Shekelle PG, Takata GS (2010) Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 304(19):2161-2169
63. Casey JR, Adlowitz DG, Pichichero ME (2010) New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 29(4):304-309
64. Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ (2010) Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis 10:90
65. Pichichero ME, Casey JR (2007) Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298(15):1772-1778 (Pubitemid 47598445)
66. Licciardi PV, Toh ZQ, Dunne E, Wong SS, Mulholland EK, Tang M, Robins-Browne RM, Satzke C (2012) Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome. PLoS Pathog 8(6):e1002652
67. O'Grady KA, Krause V, Andrews R (2009) Immunisation coverage in Australian Indigenous children: time to move the goal posts. Vaccine 27(2):307-312
68. Tagg JR, Dierksen KP (2003) Bacterial replacement therapy: adapting 'germ warfare' to infection prevention. Trends Biotechnol 21(5):217-223 (Pubitemid 36515075)
69. Leach AJ, Morris PS, Mathews JD; Chronic Otitis Media Intervention Trial - One (COMIT1) group (2008) Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial. BMC Pediatr 8:23
70. Mackenzie GA, Carapetis JR, Leach AJ, Morris PS (2009) Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination. BMC Pediatr 9:14
71. Dunbar M, Moberley S, Nelson S, Leach AJ, Andrews R (2007) Clear not simple: an approach to community consultation for a maternal pneumococcal vaccine trial among Indigenous women in the Northern Territory of Australia. Vaccine 25(13):2385-2388 (Pubitemid 46366116)
72. Gray BM, Converse GM 3rd, Dillon HC Jr (1980) Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 142(6):923-933 (Pubitemid 11153261)
73. Leiberman A, Dagan R, Leibovitz E, Yagupsky P, Fliss DM (1999) The bacteriology of the nasopharynx in childhood. Int J Pediatr Otorhinolaryngol 49(Suppl 1):S151-S153
74. Principi N, Marchisio P, Schito GC, Mannelli S (1999) Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J 18(6):517-523 (Pubitemid 29277615)
75. Coates H, Thornton R, Langlands J, Filion P, Keil AD, Vijayasekaran S, Richmond P (2008) The role of chronic infection in children with otitis media with effusion: evidence for intracellular persistence of bacteria. Otolaryngol Head Neck Surg 138(6):778-781 (Pubitemid 351707534)
76. Food and Agriculture Organization (FAO)/World Health Organization (WHO) (2001) Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Córdoba, Argentina, 1 to 4 October 2001
77. Iannitti T, Palmieri B (2010) Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 29(6):701-725
78. Alvarez-Olmos MI, Oberhelman RA (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 32(11):1567-1576 (Pubitemid 32458724)
79. Santagati M, Scillato M, Patanè F, Aiello C, Stefani S (2012) Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol 65(1):23-31
80. Wescombe PA, Heng NCK, Burton JP, Chilcott CN, Tagg JR (2009) Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol 4(7):819-835
81. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC (2009) Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 15(2):300-310
82. Olivares M, Díaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonollá J, Navas M, Rodríguez JM, Xaus J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23(3):254-260 (Pubitemid 46367573)
83. Mullié C, Yazourh A, Thibault H, Odou MF, Singer E, Kalach N, Kremp O, Romond MB (2004) Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr Res 56(5):791-795 (Pubitemid 39403407)
84. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A, Sata M (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140(3):417-426 (Pubitemid 40813951)
85. Taverniti V, Minuzzo M, Arioli S, Junttila I, Hämäläinen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S (2012) In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product. Appl Environ Microbiol 78(12):4209-4216
86. Licciardi PV, Tang ML (2011) Vaccine adjuvant properties of probiotic bacteria. Discov Med 12(67):525-533
87. Popova M, Molimard P, Courau S, Crociani J, Dufour C, Le Vacon F, Carton T (2012) Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens. J Appl Microbiol 113(6):1305-1318
88. Niittynen L, Pitkäranta A, Korpela R (2012) Probiotics and otitis media in children. Int J Pediatr Otorhinolaryngol 76(4):465-470
89. Glück U, Gebbers JO (2003) Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77(2):517-520 (Pubitemid 36133398)
90. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, Saxelin M, Korpela R (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322(7298):1327
91. Stecksén-Blicks C, Sjöström I, Twetman S (2009) Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: a cluster-randomized study. Caries Res 43(5):374-381
92. Hatakka K, Blomgren K, Pohjavuori S, Kaijalainen T, Poussa T, Leinonen M, Korpela R, Pitkäranta A (2007) Treatment of acute otitis media with probiotics in otitis-prone children - a double-blind, placebo-controlled randomised study. Clin Nutr 26(3):314-321 (Pubitemid 46760476)
93. Rautava S, Salminen S, Isolauri E (2009) Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. Br J Nutr 101(11):1722-1726
94. Taipale T, Pienihäkkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P, Jokela J, Söderling E (2011) Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 105(3):409-416
95. Roos K, Håkansson EG, Holm S (2001) Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. Brit Med J 322(7280):210-212 (Pubitemid 32116166)
96. Bernstein JM, Sagahtaheri-Altaie S, Dryja DM, Wactawski-Wende J (1994) Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta Otorhinolaryngol Belg 48(1):1-9
97. Tano K, Grahn Håkansson E, Holm SE, Hellström S (2002) A nasal spray with alpha-haemolytic streptococci as long term prophylaxis against recurrent otitis media. Int J Pediatr Otorhinolaryngol 62(1):17-23 (Pubitemid 33103935)
98. Tano K, Olofsson C, Grahn-Håkansson E, Holm SE (1999) In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children. Int J Pediatr Otorhinolaryngol 47(1):49-56 (Pubitemid 29093710)
99. Douglas CWI, Heath J, Hampton KK, Preston FE (1993) Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol 39(3):179-182 (Pubitemid 23279692)
100. Sprunt K, Leidy G, Redman W (1980) Abnormal colonization of neonates in an ICU: conversion to normal colonization by pharyngeal implantation of alpha hemolytic Streptococcus strain 215. Pediatr Res 14(4):308-313 (Pubitemid 10156092)
101. Skovbjerg S, Roos K, Holm SE, Grahn Håkansson E, Nowrouzian F, Ivarsson M, Adlerberth I, Wold AE (2009) Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child 94(2):92-98
102. Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, Albera R (2012) Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int J Gen Med 5:991-997
103. Bernstein JM, Haase E, Scannapieco F, Dryja D, Wolf J, Briles D, King J, Wilding GE (2006) Bacterial interference of penicillin-sensitive and -resistant Streptococcus pneumoniae by Streptococcus oralis in an adenoid organ culture: implications for the treatment of recurrent upper respiratory tract infections in children and adults. Ann Otol Rhinol Laryngol 115(5):350-356 (Pubitemid 43736846)
104. Birri DJ, Brede DA, Nes IF (2012) Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl Environ Microbiol 78(2):402-410
105. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, Karp M, Mora D (2010) Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl Environ Microbiol 76(12):3948-3958
106. Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR (2006) Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol 72(4):3050-3053
107. Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR (2011) Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 49(9):2356-2364
108. Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C (2013) Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther 13(3):399-343
109. Power DA, Burton JP, Chilcott CN, Dawes PJ, Tagg JR (2008) Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis 27(12):1261-1263
110. Villena J, Oliveira ML, Ferreira PC, Salva S, Alvarez S (2011) Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. Int Immunopharmacol 11(11):1633-1645
111. Salva S, Villena J, Alvarez S (2010) Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int J Food Microbiol 141(1-2):82-89
112. Villena J, Barbieri N, Salva S, Herrera M, Alvarez S (2009) Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei. Microbiol Immunol 53(11):636-646